$PKE
PARK AEROSPACE CORP

2023 Q4 Form 10-Q Financial Statement

#000143774923027819 Filed on October 06, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $11.64M $12.48M
YoY Change -16.07% -10.05%
Cost Of Revenue $8.470M $8.402M
YoY Change -10.11% -14.17%
Gross Profit $3.169M $4.079M
YoY Change -28.69% -0.17%
Gross Profit Margin 27.23% 32.68%
Selling, General & Admin $1.804M $1.853M
YoY Change 18.45% 6.99%
% of Gross Profit 56.93% 45.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $340.0K $339.0K
YoY Change 11.48% 29.89%
% of Gross Profit 10.73% 8.31%
Operating Expenses $1.804M $1.853M
YoY Change 18.45% 6.99%
Operating Profit $1.365M $2.226M
YoY Change -53.27% -5.44%
Interest Expense $261.0K $139.0K
YoY Change -12.71% -37.1%
% of Operating Profit 19.12% 6.24%
Other Income/Expense, Net
YoY Change
Pretax Income $1.626M $2.365M
YoY Change -49.5% -8.16%
Income Tax $423.0K $619.0K
% Of Pretax Income 26.01% 26.17%
Net Earnings $1.203M $1.746M
YoY Change -46.05% -7.37%
Net Earnings / Revenue 10.34% 13.99%
Basic Earnings Per Share $0.06 $0.09
Diluted Earnings Per Share $0.06 $0.09
COMMON SHARES
Basic Shares Outstanding 20.25M 20.25M
Diluted Shares Outstanding 20.36M 20.34M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $73.99M $74.21M
YoY Change -28.38% -27.57%
Cash & Equivalents $4.173M $7.363M
Short-Term Investments $69.82M $66.85M
Other Short-Term Assets $2.463M $2.587M
YoY Change -42.24% -34.79%
Inventory $7.421M $8.457M
Prepaid Expenses
Receivables $9.897M $9.374M
Other Receivables $0.00 $0.00
Total Short-Term Assets $93.77M $94.63M
YoY Change -23.95% -23.83%
LONG-TERM ASSETS
Property, Plant & Equipment $23.75M $23.98M
YoY Change -2.1% -1.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $98.00K $101.0K
YoY Change -12.5% -12.93%
Total Long-Term Assets $33.74M $33.99M
YoY Change -1.7% -1.6%
TOTAL ASSETS
Total Short-Term Assets $93.77M $94.63M
Total Long-Term Assets $33.74M $33.99M
Total Assets $127.5M $128.6M
YoY Change -19.11% -18.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.110M $1.535M
YoY Change -53.07% -45.18%
Accrued Expenses $1.587M $1.167M
YoY Change 24.96% 8.86%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.429M $6.788M
YoY Change 1.28% -4.96%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.843M $1.812M
YoY Change -60.37% -59.25%
Total Long-Term Liabilities $1.843M $1.812M
YoY Change -60.37% -59.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.429M $6.788M
Total Long-Term Liabilities $1.843M $1.812M
Total Liabilities $15.52M $15.91M
YoY Change -35.36% -35.65%
SHAREHOLDERS EQUITY
Retained Earnings -$45.51M -$44.18M
YoY Change 82.92% 76.28%
Common Stock $2.096M $2.096M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $12.02M $12.04M
YoY Change 31.3% 31.45%
Treasury Stock Shares
Shareholders Equity $112.0M $112.7M
YoY Change
Total Liabilities & Shareholders Equity $127.5M $128.6M
YoY Change -19.11% -18.99%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $1.203M $1.746M
YoY Change -46.05% -7.37%
Depreciation, Depletion And Amortization $340.0K $339.0K
YoY Change 11.48% 29.89%
Cash From Operating Activities $1.759M -$2.762M
YoY Change -54.16% 58.1%
INVESTING ACTIVITIES
Capital Expenditures $107.0K $207.0K
YoY Change -201.9% -137.23%
Acquisitions
YoY Change
Other Investing Activities -$2.322M $8.238M
YoY Change 154.88% 121.87%
Cash From Investing Activities -$2.429M $8.031M
YoY Change 139.07% 154.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.520M -3.742M
YoY Change 23.11% 96.22%
NET CHANGE
Cash From Operating Activities 1.759M -2.762M
Cash From Investing Activities -2.429M 8.031M
Cash From Financing Activities -2.520M -3.742M
Net Change In Cash -3.190M 1.527M
YoY Change -512.14% -407.24%
FREE CASH FLOW
Cash From Operating Activities $1.759M -$2.762M
Capital Expenditures $107.0K $207.0K
Free Cash Flow $1.652M -$2.969M
YoY Change -58.09% 149.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
6561000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1703000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
27141000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
24466000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3319000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4092000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
139000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28441000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
159333000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
12.14
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-26
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000076267
pke Number Of Insurance Carriers
NumberOfInsuranceCarriers
3 pure
pke Number Of Units Covered Under General Liability Insurance Coverage
NumberOfUnitsCoveredUnderGeneralLiabilityInsuranceCoverage
2 pure
CY2023Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
0 usd
pke Number Of Units Covered Under General Liability Insurance Coverage
NumberOfUnitsCoveredUnderGeneralLiabilityInsuranceCoverage
2 pure
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7363000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4237000 usd
CY2023Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
66851000 usd
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
101203000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
128000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
120000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9374000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9989000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
8457000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
6768000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2587000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2844000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
94632000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
125041000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23980000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24251000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
123000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
150000 usd
CY2023Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
9783000 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
9783000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
101000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
108000 usd
CY2023Q3 us-gaap Assets
Assets
128619000 usd
CY2023Q1 us-gaap Assets
Assets
159333000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1535000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4545000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
53000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
53000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1167000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1346000 usd
CY2023Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
20471000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4033000 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2171000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6788000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
28586000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
106000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
129000 usd
CY2023Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
5259000 usd
CY2023Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
10938000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1942000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1995000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1812000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1751000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
15907000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
43399000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2096000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2096000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
170254000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
169932000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44184000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42694000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3418000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4244000 usd
CY2023Q3 pke Stockolders Equity Including Treasury Stock
StockoldersEquityIncludingTreasuryStock
124748000 usd
CY2023Q1 pke Stockolders Equity Including Treasury Stock
StockoldersEquityIncludingTreasuryStock
125090000 usd
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
12036000 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
9156000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
112712000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
115934000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128619000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12481000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13875000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28032000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
26658000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8402000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9789000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19120000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18480000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
4079000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
4086000 usd
us-gaap Gross Profit
GrossProfit
8912000 usd
us-gaap Gross Profit
GrossProfit
8178000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1853000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1732000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4468000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3365000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2226000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2354000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
4444000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
4813000 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
139000 usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
221000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
463000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
354000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2365000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2575000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4907000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5167000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
619000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
690000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1307000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1372000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1746000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1885000 usd
us-gaap Net Income Loss
NetIncomeLoss
3600000 usd
us-gaap Net Income Loss
NetIncomeLoss
3795000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20256000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20461000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20359000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20460000
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20338000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20503000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20432000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20504000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1746000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1885000 usd
us-gaap Net Income Loss
NetIncomeLoss
3600000 usd
us-gaap Net Income Loss
NetIncomeLoss
3795000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
110000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-667000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
826000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1600000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1856000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1218000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4426000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2195000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
3600000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
3795000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
644000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
521000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
322000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
179000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
8000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-52000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
368000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
408000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-5000 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-184000 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-0 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
7759000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3329000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
37915000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
34212000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
25561000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2880000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3953000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3126000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8975000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4237000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12811000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7363000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3836000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
66851000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
101203000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
71533000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4682000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
107017000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5814000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
10718000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
56133000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
66851000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
801275
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P6Y10D
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6960000 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5376000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
348000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
536000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1149000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
856000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
8457000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
6768000 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
16000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
31000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
123000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
53000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
106000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
159000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y2M12D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
109000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
670425
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.80
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
838000000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
133300
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.08
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
-0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
2450
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
833000000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
481350
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.81
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y2M26D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
597000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1746000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1885000 usd
us-gaap Net Income Loss
NetIncomeLoss
3600000 usd
us-gaap Net Income Loss
NetIncomeLoss
3795000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20256000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20461000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20359000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20460000
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
82000
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
42000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
73000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
44000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20338000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20503000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20432000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20504000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2022Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1500000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
221099
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
619000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1307000 usd
CY2023Q3 pke Income Tax Expense Benefit Discrete Amount
IncomeTaxExpenseBenefitDiscreteAmount
16000 usd
pke Income Tax Expense Benefit Discrete Amount
IncomeTaxExpenseBenefitDiscreteAmount
53000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
690000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1372000 usd
CY2022Q3 pke Income Tax Expense Benefit Discrete Amount
IncomeTaxExpenseBenefitDiscreteAmount
48000 usd
pke Income Tax Expense Benefit Discrete Amount
IncomeTaxExpenseBenefitDiscreteAmount
75000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.262 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.266 pure
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.268 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.266 pure
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q2 us-gaap Undistributed Earnings
UndistributedEarnings
25000000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28032000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
26658000 usd
CY2023Q3 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody><tr style="vertical-align: top;"> <td style="width: 18pt;"> <p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>11. </b></p> </td> <td style="width: auto;"> <p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>CONTINGENCIES</b></p> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Litigation</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is subject to a small number of immaterial proceedings, lawsuits and other claims related to environmental, employment, product and other matters. The Company is required to assess the likelihood of any adverse judgments or outcomes in these matters as well as potential ranges of probable losses. A determination of the amount of reserves required, if any, for these contingencies is made after careful analysis of each individual issue. The required reserves may change in the future due to new developments in each matter or changes in approach, such as a change in settlement strategy in dealing with these matters. The Company believes that the ultimate disposition of such proceedings, lawsuits and claims will not have a material adverse effect on the liquidity, capital resources, business, consolidated results of operations or financial position of the Company.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Environmental Contingencies</span></i><i> </i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company and certain of its subsidiaries have been named by the Environmental Protection Agency (the “EPA”) or a comparable state agency under the Comprehensive Environmental Response, Compensation and Liability Act (the “Superfund Act”) or similar state law as potentially responsible parties in connection with alleged releases of hazardous substances at three sites.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Under the Superfund Act and similar state laws, all parties who may have contributed any waste to a hazardous waste disposal site or contaminated area identified by the EPA or comparable state agency may be jointly and severally liable for the cost of cleanup. Generally, these sites are locations at which numerous persons disposed of hazardous waste. In the case of the Company’s subsidiaries, generally the waste was removed from their manufacturing facilities and disposed at waste sites by various companies which contracted with the subsidiaries to provide waste disposal services. Neither the Company nor any of its sub‐sidiaries have been accused of or charged with any wrongdoing or illegal acts in connection with any such sites. The Company believes it maintains an effective and comprehensive environmental compliance program.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The insurance carriers which provided general liability insurance coverage to the Company and its subsidiaries for the years dur‐ing which the Company’s subsidiaries’ waste was disposed at these three sites have in the past reimbursed the Company and its subsidiaries for 100% of their legal defense and remediation costs associated with <span style="-sec-ix-hidden:c844">two</span> of these sites.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company does <span style="-sec-ix-hidden:c845">not</span> record environmental liabilities and related legal expenses for which the Company believes that it and its subsidiaries have general liability insurance coverage for the years during which the Company’s subsidiaries’ waste was disposed at <span style="-sec-ix-hidden:c846">two</span> sites for which certain subsidiaries of the Company have been named as potentially responsible parties. Pursuant to such general liability insurance coverage, <span style="-sec-ix-hidden:c847">three</span> insurance carriers reimburse the Company and its subsidiaries for 100% of the legal defense and remediation costs associated with the two sites.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Included in selling, general and administrative expenses are charges for actual expenditures and accruals, based on estimates, for certain environmental mat‐ters described above. The Company accrues estimated costs asso‐ciated with known environmental matters when such costs can be reasonably estimated and when the outcome appears probable. The Company believes that the ultimate disposition of known environmental matters will not have a material adverse effect on the Company’s results of operations, cash flows or financial position.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
pke Percentage Of Legal Defense And Remediation Costs Associated With Sites Reimbursed By Insurance Carriers
PercentageOfLegalDefenseAndRemediationCostsAssociatedWithSitesReimbursedByInsuranceCarriers
1 pure

Files In Submission

Name View Source Status
0001437749-23-027819-index-headers.html Edgar Link pending
0001437749-23-027819-index.html Edgar Link pending
0001437749-23-027819.txt Edgar Link pending
0001437749-23-027819-xbrl.zip Edgar Link pending
ex_573532.htm Edgar Link pending
ex_573533.htm Edgar Link pending
ex_573534.htm Edgar Link pending
ex_573535.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pke-20230827.xsd Edgar Link pending
pke20230827_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
pke-20230827_cal.xml Edgar Link unprocessable
pke-20230827_pre.xml Edgar Link unprocessable
pke-20230827_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pke-20230827_lab.xml Edgar Link unprocessable
pke20230827_10q_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending